Journal of Postgraduate Medicine, Education and Research (JPMER) is an open access, peer reviewed, quarterly published, multidisciplinary journal that aims to publish cutting-edge basic, translational, and clinical research papers of the highest quality. It accepts submissions from writers worldwide with the goal of publishing research that may influence medical practice globally.
Manuscripts must be submitted exclusively via the online submission process, adhering to the instructions provided below:
All authors interested in publishing their research work in Journal of Postgraduate Medicine, Education and Research (JPMER) will need to submit their manuscripts for publication through a web-based manuscript tracking system (MTS). The authors can submit new manuscript, revise their existing manuscripts, upload other required documents on the MTS. MTS also provides for tracking the status of the manuscripts, that are already submitted. This system helps the editorial office to communicate with the editors, associate editors, reviewers and thus manage the peer review process. The same system is used for communication with authors. Please go to Manuscript tracker and register yourself (if first time user) to submit the manuscripts. Manuscripts are received with the understanding that they contain original data that are not previously published or are being considered for publication elsewhere. In case of any queries or additional information, you can write an e-mail to the Editor-in-Chief of the journal at editor@jpmer.com.
The submitted manuscripts are duly acknowledged. The article once submitted will undergo plagiarism check. An initial check is conducted to ensure that all author instructions are complied with and the guidelines for submission are followed. All communications regarding the manuscript with the Journal should be handled by one of the authors (assigned as ‘corresponding author’). The Managing editor runs the initial check, processes the manuscript for all the required components, and approves for moving to the next level. The manuscript may be returned to the author for corrections, if required, to conform to the journal instructions.
Once, the article passes the initial check, it will undergo editorial review. Here, the manuscript is checked for suitability for the core readers of Journal of Postgraduate Medicine, Education and Research (JPMER) by the Editor-in-Chief. If it is found suitable, it is assigned to one of the Editorial Board Members. The editorial review which includes initial assessment and assignment for review will take 7 – 10 working days. Manuscripts not found suitable will not be sent out for review and will be immediately rejected, and authors informed.
Once the manuscript passes the editorial review, it will then be sent for external peer review. Manuscripts are sent to a minimum of two independent expert reviewers to assess the scientific quality of the manuscript. All manuscripts undergo a double-blinded review process. The Editor-in-Chief makes a final recommendation (revise/ accept/ reject) on the manuscript based on the suggestions and comments of the reviewers. The authors will be informed of the first decision in 8 – 10 weeks from the date of submission. If a manuscript must be revised, the author(s) are asked to give a detailed response to the reviewers' suggestions and submit the revised manuscript for further review. Decisions on the revised manuscripts will be conveyed within 4 weeks from the date of re-submission. This process is repeated till the authors, reviewers and editors are satisfied with the manuscript. The authors can track the progress of the manuscript through https://www.jpmer.com/manuscriptTrack/JPMER.
The manuscript will be assessed for significance, originality, clarity, and relevance to the journal's scope and content, Studies that challenge previously published research or have negative results despite having sufficient power will also be considered. Manuscripts received from Editorial Board members will be screened by the Editor in Chief and sent to external peer reviewers. Manuscripts authored by the Editor in Chief will be handled by the other editorial board members, and the final decision will be made by the Associate editor/ Editor. The editorial board members who are authors will be excluded from publication decisions. The journal's standard procedures are followed for manuscripts received from the members of sponsoring organization/ institution wherein the members linked with the same institution as the author (s) are excluded from the review and editorial decisions.
Genuine appeals to editor decisions are welcome. The authors can appeal if they have a genuine cause to believe that the editorial board has wrongly rejected the paper. If the authors wish to appeal against the editor’s decision, they should email the editorial office editor@jaypeebrothers.com / editor@jpmer.com explaining in detail the basis for the appeal with evidence or new information. The editorial office will acknowledge the appeals and conduct an unbiased investigation. Within 6 to 8 weeks, appeals will be processed, and the decision will be conveyed to the authors. Till the time of decision, the paper should not be submitted to other journals. The Editor-in-Chief of the journal makes the final decision. Second appeals will not be considered.
There are no article processing charges for publication of an article in the journal.
Journal of Postgraduate Medicine, Education and Research (JPMER) is a quarterly publication.
Under Creative Commons the Authors retain ownership of the copyright for their content. The authors assign exclusive commercial re-use rights of the article to the Publisher.
All open access articles published are distributed under the terms of the CC BY-NC 4.0 license (Creative Commons Attribution-Non-Commercial 4.0 International Public License as currently displayed at http://creativecommons.org/licenses/by-nc/4.0/legalcode) which permits unrestricted use, distribution, and reproduction in any medium, for non-commercial purposes, provided the original work is properly cited.
Authors have to mandatorily submit the Open Access License Agreement Form
Articles published under this arrangement are made freely available online upon publication without subscription barriers to access. Users of such published articles are entitled to use, reproduce, disseminate, or display these articles for personal, research and educational use provided that:
The journal upholds a stringent anti-plagiarism policy. Submitted manuscripts undergo a thorough plagiarism check before the review process. If any form of plagiarism is detected, the manuscript will be promptly returned or rejected. Authors re-using figures/tables from other sources, whether previously published or copyrighted, must furnish documentation demonstrating permission from the original publisher or copyright holder for republication.
The journal follows World Association of Medical Editors (WAME’s) definition of plagiarism: “Plagiarism is the use of others' published and unpublished ideas or words (or other intellectual property) without attribution or permission and presenting them as new and original rather than derived from an existing source. The intent and effect of plagiarism is to mislead the reader as to the contributions of the plagiarizer. This applies whether the ideas or words are taken from abstracts, research grant applications, Institutional Review Board applications, or unpublished or published manuscripts in any publication format (print or electronic)”.
The journal follows a strict anti-plagiarism policy. The authors are advised not to indulge in any form of plagiarism. The journal investigates allegations of plagiarism or the unauthorised use of published content to uphold the rights of our authors. We also work to guard the journal's reputation against unethical practices.
The submitted article are checked with duplication-checking software. If the content is found to be plagiarised, the Editor and the journal committee will take an appropriate action as directed by the guidelines put forth by the Committee on Publication Ethics (COPE). If plagiarism is detected after publication, the Journal will initiate investigation. If plagiarism is established, the Journal reserves the right to act including, but not limited to notifying the authors’ institution and funding bodies, retracting the plagiarised article or taking appropriate legal action. To report plagiarism, contact the journal office at editor@jaypeebrothers.com. For further information about the policy on publication malpractice or research misconduct, refer to the policy page https://www.jpmer.com/journal/JPMER/page/policy.
The Journal adheres to the policies outlined by ICMJE regarding the use of artificial intelligence (AI) in manuscript preparation.
a) Authors must disclose in their manuscript submission whether AI-assisted technologies, such as ChatGPT/Chatbots, Jasper, Image Creator, STOCKIMG.AI, etc., were utilized in producing the submitted work. The manuscript should provide a description of the technologies used and their output.
b) AI-assisted technologies cannot be listed as authors since the authors bear full responsibility for the accuracy, integrity, and originality of the work.
c) Authors are urged to meticulously review and edit all AI-generated materials to avoid submitting content that may appear authoritative but is inaccurate, incomplete, or biased.
d) Authors must ensure that all text and images generated by AI are free from plagiarism. Proper attribution, including full citations, must be provided for all quoted material.
e) Citation of AI-generated material as a primary source is not deemed acceptable and should be avoided.
The journal follows the recommendations of the International Committee of Medical Journal Editors (ICMJE).
As per the CARE reporting guidelines, the patient or the legal guardian must provide a written informed consent for inclusion of their clinical and imaging details in the manuscript for the purpose of publication. The submitted manuscript needs to contain a statement that informed consent was obtained from the patient for the purpose of publication.
Click to download the Patient Consent form
All papers reporting studies involving human participants, human data or human tissue must state:
If the ethical approval is not required or is exempt, then a statement mentioning the same should be included in the submitted manuscript, with reasons for the same.
A statement about whether written or verbal informed consent was obtained from the patients to participate in the research should be included in the submitted manuscript. If the requirement for informed consent to participate has been waived by the Ethics Committee or Institutional Review Board (i.e., where it has been deemed that consent would be impossible or impracticable to obtain), please state this.
Authors must confirm that animal experiments complied with applicable guidelines and regulations, and provide details of the institutional and/or licensing committee that approved the experiments. It is important to describe the sex and characteristics of animals, as well as housing and husbandry conditions, if they influence the results. Authors should follow the ARRIVE guidelines (PLoS Bio 8(6), e1000412, 2010) for documenting studies and consult the AVMA Guidelines for the Euthanasia of Animals (2020) to ensure compliance with veterinary best practices for anaesthesia and euthanasia.
When using human cell lines, authors must specify the origin, authentication, and details of the cell lines used. This includes the source of the cell line, its authentication status and method, and details if purchased from a life science company (e.g., company name, cell type, cell line number, and batch). Authors should verify cell line identity and contamination through the NCBI database to pre-empt potential issues. Further guidance is provided by the International Cell Line Authentication Committee (ICLAC).
Studies Involving Human Stem Cells: Manuscripts should confirm compliance with relevant guidelines and regulations for experiments involving human stem cells and related materials. The ethics statement must name the approving institutional and/or licensing committees, describe any specifics, and confirm that informed consent was obtained from all cell or tissue donors and recipients, detailing donation conditions. We recommend following the 2016 ISSCR Guidelines for Stem Cell Research and Clinical Applications of Stem Cells. Ethical and regulatory considerations should be addressed concurrently with the scientific peer review.
Images: For publications containing identifiable human images, authors must include a statement affirming that informed consent for publication was obtained. All reasonable measures should be taken to protect patient anonymity; mere use of black bars over the eyes is insufficient. In some instances, proof of consent may be required, and images without appropriate consent will be omitted from publication.
Tumour Marker Prognostic Studies: Authors of studies on tumour markers are urged to follow the REMARK guidelines for thorough and transparent reporting.
The journal follows the recommendations of the International Committee of Medical Journal Editors (ICMJE) for clinical trial registration (https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html ). According to ICMJE, “Clinical trial is any research project that prospectively assigns people or a group of people to an intervention, with or without concurrent comparison or control groups, to study the relationship between a health-related intervention and a health outcome.”
Authors are required to include a Data Availability Statement in their manuscripts that outlines the accessibility of research data supporting their findings. This statement should detail where the data can be located, specifying whether the dataset is:
a. Deposited in a named repository.
b. Available within the article or its supplementary materials.
c. Accessible upon reasonable request from a designated contact (provide contact name and email address).
d. Available in a public domain resource.
e. Subject to an embargo period due to commercial restrictions or other reasons.
If the data are not publicly available, the statement must also disclose this fact and describe the conditions under which the data can be accessed. This ensures transparency and enables reproducibility of the research findings.
JPMER follows the ICMJE recommendations on authorship. According to the ICMJE, all authors should have participated sufficiently in the work to take public responsibility for the content, either all the work or an important part of it. To take public responsibility, an author must be able to defend the content (all or an important part) and conclusions of the article if publicly challenged. Sufficient participation means that substantial contributions have been made in each of the following areas:
a) Conception and design of the work; or acquisition, analysis, or interpretation of the data for the work.
b) Drafting the work or revising it critically for important intellectual content.
c) Approval of the version to be published.
d) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged.
When submitting a paper with equal co-authorship, authors have the option to denote dual first or senior authorship by placing an asterisk on the manuscript title page.
JPMER allows only one corresponding author for each submitted manuscript, who is exclusively responsible for handling all communication with the Journal and will receive all relevant emails concerning the submission. However, following acceptance for publication, authors may nominate multiple individuals to be contacted by readers..
The journal considers the final author list (names and the authorship sequence) to be complete at the time of submission of the Open Access License Agreement form. Request for removal or addition of an author after signing the Agreement will not be entertained. If the authors have a genuine reason for changes to authorship and authorship sequence, the authors should complete the “Authorship change request form” with a signed statement of agreement for the requested change from all listed authors and from the author to be removed or added and send it to editor@jpmer.com along with a letter explaining the reasons for the proposed changes. The Journal Editor-in-Chief will consider these requests on a case-to-case basis.
All the authors are required to provide an ORCiD when submitting the manuscript to the journal. Authors can register for an ORCiD at https://orcid.org/register
The authors are required to provide information about their individual contributory roles according to CRediT (Contributor Roles Taxonomy). There are 14 selections that the authors can choose from, and more than one contribution can be selected for each author. Authors can refer to https://credit.niso.org for more information.
Contributors who meet fewer than all 4 of the above criteria for authorship should not be listed as authors, but they should be acknowledged. The “Acknowledgement section” should specify 1) contributions that need acknowledging but do not justify authorship, such as general support by a departmental chair; 2) acknowledgments of technical help; 3) writing assistance, technical editing, language editing, and proofreading; and 4) acknowledgments of financial and material support, which should specify the nature of the support. Details of the non-author contributors can be cited individually or collectively, and their precise contributions should be specified. The corresponding author is required to obtain written permission to be acknowledged by all acknowledged individuals. Click to download Acknowledgement Form.
Authors must disclose any financial interests or affiliations with institutions, organizations, or companies mentioned in the manuscript, or whose products and services are referenced therein. Additionally, any competing interests that could potentially bias the work must be disclosed. If an editorial board member is an author, a statement to that effect should be included. Authors must complete the ICMJE Disclosure Form upon submission.
The authors are required to declare the funding sources received for the research submitted to the journal. The authors should provide the Funder name, Award Number and Grant Recipient, the role of funders. If there are no funders, the authors must state "This study did not receive any funding."
The figures, data tables and charts that are submitted should be owned solely by the author(s). If this requirement cannot be fulfilled, then the author(s) should acquire the permission from the original copyright holder for the purpose of re-use in the journal. Obtaining the permission is the sole responsibility of the author(s) and should be completed before the acceptance of the article in the journal. Credit must be included for all copyrighted material in the figure legend with a statement that the permission has been obtained.
The journal permits submissions of papers that have been posted on pre-print servers. The authors should mention this in the title page when submitting and include the name of the preprint server and DOI for the preprint. Authors should not post an updated version of their paper on the preprint server while it is being peer reviewed. If the paper is accepted, the authors must include a link on the preprint to the final version of your paper.
All types of submissions / papers should follow a standard format as described in the below “Manuscript Component” section.
EQUATOR Network reporting guidelines (https://www.equator-network.org/reporting-guidelines/) must be followed depending on the type of study. At the time of submission, the authors should upload the relevant checklist for the specific study type. The EQUATOR wizard (https://www.goodreports.org/) can help you find the right reporting checklist and appropriate guideline for your type of study. Other resources can be found at NLM’s Research Reporting Guidelines and initiatives (https://www.nlm.nih.gov/services/research_report_guide.html).
Usually offer insights and evaluations on an article that appears in the Journal issue in which they appear. While editorials are typically invited, unsolicited submissions are accepted and will be taken into consideration.
The journal focuses on different types of research articles that include case-control studies, cohort studies, randomized trials, intervention studies, screening and diagnostic test evaluations, laboratory and animal studies, cost-effectiveness analyses, and high-response-rate surveys and other unpublished works that are likely to have a significant impact in the field. Reports of original clinical and basic research of interest are the primary material to be published as original articles.
Review articles on selected clinical and basic topics of interest to our readers are generally solicited by the Editors. However, unsolicited articles are also welcome if they present a comprehensive overview of the state of the art, rather than merely summarizing the literature. These articles should discuss current issues, problems, controversies, research gaps, and potential developments in the field in a clear and concise manner.
Articles that provide critical assessments of the literature and data sources related to clinical topics, focusing on factors such as cause, diagnosis, prognosis, therapy, or prevention, will be considered systematic reviews. Articles that include a statistical technique for quantitatively combining the results of multiple studies measuring the same outcome into a single pooled or summary estimate will be considered meta-analyses and published as Original Research
Types: Systematic reviews, meta-analysis, narrative reviews, scoping reviews
A report defining 1-3 patients may be considered if it provides an outstanding contribution to the understanding of the etiology, pathogenesis, or treatment of a specific disease. They should highlight unique or novel aspects of the cases that offer valuable insights or advancements in medical knowledge. Emphasis should be placed on how these cases enhance understanding of disease mechanisms, contribute to developing new treatment strategies, or challenge existing paradigms. These reports must demonstrate significant potential to influence future research or clinical practice.
Case-series is a descriptive study design and as the name suggests, it is just a series of cases of any disease or disease discrepancy that one might observe in one’ clinical practice etc.
Present a new method, protocol, technique, or development of a device that holds significant interest and potential impact in the medical field. This should include a detailed description of the innovation, its underlying principles, and its application. Emphasize how this advancement addresses current limitations, improves upon existing solutions, or introduces novel approaches. Additionally, provide evidence of its effectiveness and potential benefits through preliminary data, case studies, or pilot trials, and discuss its implications for future research, clinical practice, and patient care.
These articles offer concise presentations of descriptive study designs, preliminary experimental results, instrumentation, analytical techniques, or aspects of clinical or experimental practice that are not yet fully investigated, verified, or perfected but may be of widespread interest or application. Submissions may also include interesting cases or series with unique features that have not been previously described and that provide significant teaching points or scientific observations. The Editors reserve the right to determine what qualifies as a Short Communication.
Articles featuring outstanding research conducted by residents/PhD scholars; Clinical challenges, quizzes, or unique images with notable clinical implications; Perspectives on current issues with potential solutions; and Concise, constructive responses to previously published articles in the Journal of Postgraduate Medicine Education and Research. The resident/fellow/Scholar should be the first author of the manuscript to be published as resident’s corner.
A brief report on clinically challenging or undiagnosed cases confirmed by post-mortem should include detailed patient history, symptoms, and initial diagnostics. It should focus on clinical challenges, such as atypical presentations and inconclusive results. The report should then detail the postmortem examination, highlighting histological and laboratory findings that revealed the final diagnosis. Additionally, it should discuss broader clinical implications, lessons learned, missed diagnostic opportunities, and recommendations for future cases. Emphasis should be on how these findings enhance understanding of the disease, guiding future research and improving diagnostic strategies.
These articles are written by one or more recognized experts in the field. If there is more than one author, all authors should be experts in the field. The article should offer a step-by-step guide on how they would approach a patient with a given disease, based on their clinical experience and expertise. Flow charts and images will be encouraged.
These articles are written by a group of clinicians/scientists who are specialists in a given field and the recommendations are based on a thorough survey of the existing literature and on their collective clinical expertise in medical care.
A Medical Image is a photograph, photomicrograph, radiograph, or other type image, accompanied by a paragraph or 2 of descriptive text (not to exceed 250 words)and one or more supporting reference(s) (limit 5 references). Medical Images should include maximum of 5 authors and these authors must reflect the specialty(s) of the image(s) submitted. A minimum of 1 image with a maximum of 4 images may be submitted. Each image must have its own legend (60 characters or less).
The Journal accepts Letters to the Editor that raises some issues related to recently published articles (last 6 months) in the Journal of Postgraduate Medicine, Education and Research. The letters should not exceed (1000 words) of text and 4 references. While not all “Letters to the Editor” will be published, those that are judged worthwhile will be forwarded to the authors of the articles in question or to selected experts in order to provide the opportunity for a response. Whenever possible, they will be published with the reply of the author of the published article.
Books for review will be posted on the journal, and received reviews will be published, at the discretion of the Editorial Board. Every book up for review shall also be reviewed by certain reviewers on invitation by the Editorial Board, usually a stalwart/pioneer in the subject in question.
Announcement of conferences, meetings, courses, awards, and other events of interest to the readers should be submitted with the name and address of the person from whom additional information can be sought. These can contain up to 200-300 words.
The journal publishes articles related to health education and awareness.
Articles about statistical methods and its application will be published in this section.
Guidelines for the most frequent types of articles submitted to the journal are summarized below. Specific limits for word count, references, tables, and figures are provided in table format for quick reference.
| Manuscript Type | Abstract | Maximum word count | Number of references | Tables/ figures/ Illustrations | Other requirements |
|---|---|---|---|---|---|
| Original Research | Graphical/ Structured 250 words |
3000 | 50 | 6 | Please see reporting guideline checklist |
| Review | Graphical/ Unstructured 250 words |
5000 | 100 | Up to 8 (mandatory 3 figures and 3 Tables) |
Highlights (3-5 bullet points) |
| Systematic review/Meta analysis | Graphical/ Structured 250 words |
3000 | 75 | 6 | Highlights (3-5 bullet points) PRISMA Checklist PRISMA Flowchart |
| Editorial | - | 1000 | 10 | 1 | - |
| How do I Treat | - | 2500 | 50 | 8 | - |
| Consensus Guidelines | - | 5000 | 100 | 10 | - |
| Innovation | Structured Up to 250 words |
3000 | 40 | 6 | - |
| Medical Images | - | 250 | 5 | 4 | - |
| Short communication | Structured Up to 200 words |
1500 | 20 | 4 | - |
| Case report | Structured Up to 200 words |
1500 | 10 | 3 | - |
| Resident’s corner | - | 1500 | 10 | 3 | - |
| Clinico-Pathological conference | - | 1200 | 10 | 6 | - |
| Book reviews | - | 500 | - | - | - |
| Announcement | - | 500 | - | - | - |
| Correction | - | 500 | - | - | - |
The manuscript must have separate documents for:
Microsoft Word 97-2013 or higher document file must be used to submit a manuscript. The text must be double spaced with 1" margins and justified to the left-hand margin. Refer the "styles" or document templates. The "Normal" Word format is recommended. (Arial 12-point text is preferred) Please number all the pages.
A cover letter is a letter addressed to the Editor-in-Chief of the journal stating why the journal should consider your article for publication.
Title
The manuscript title should be positioned at the top of the first page and should not exceed 100 characters, including spaces. It should concisely convey the article's subject matter without abbreviations, questions, or subtitles. Additionally, it should include the study design, such as 'case-control study' or 'systematic review'.
Running Head: A brief running head of no more than 45 characters, including spaces, should be provided.
Name and affiliation
The manuscript title should be positioned at the top of the first page and should not exceed 100 characters, including spaces. It should concisely convey the article's subject matter without abbreviations, questions, or subtitles. Additionally, it should include the study design, such as 'case-control study' or 'systematic review'.
Running Head: A brief running head of no more than 45 characters, including spaces, should be provided. For any changes in the authorship or authorship order after the first revision submission, see Authorship Section
Author name indexing
When submitting author names please note that authors should be listed in First Name –Middle Name- Surname order. If an author is submitted as "JR Doe" or "Jane Robert Doe" the author’s name will be published in "How to cite" as "Doe JR."
Change of affiliation
If an author changes affiliation before the work is published, his or her affiliation should reflect where a major part of the work was done. The current affiliation and contact details should be listed in a footnote or in the acknowledgement section.
Corresponding Address
To include the name, address, telephone number, fax number, and e-mail of corresponding author.
Electronic Word Count of Abstract and main article (excluding abstract, references, and additional information) and number of figures and tables
All submitted manuscripts should contain a separate document - “Declarations” and include the following information. If a declaration is not applicable to the manuscript, the authors must still include the heading and state ‘Not applicable’ underneath with an explanation to justify why a declaration was not applicable.
Structured
Should be separate from the article, must be able to stand alone and should have following section headings: Background, Methods, Results and Conclusion. Non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself.
Unstructured abstract should be written in one single paragraph with no section headings
Graphical (optional but preferred)
Provide a concise, visually appealing summary of the article's contents, designed to engage a broad readership online. Authors should include images that clearly represent the work described. Submit graphical abstracts as separate image files with a minimum resolution of 300 dpi. Maintain the original image ratio if submitting a larger image
All abstracts must be organized into a structured format appropriate to the type of article using the headings listed in the following table:
| Primary Research | Literature Reviews | Case Reports |
|---|---|---|
| Aim & Background | Aim & Background | Aim & Background |
| Methods | Methods | Case Description |
| Results | Results | Conclusion |
| Conclusion | Conclusion | Clinical Significance |
| Clinical Significance | Clinical Significance |
For review and meta-analysis articles, include a brief collection of bullet points conveying the core findings of the article. Place these highlights before the Introduction section, with 3 to 5 bullet points, each limited to a maximum of 100 characters, including spaces.
Original studies, Systematic Reviews and Metaanalysis, Innovation, Short Communication and Case Reports
The manuscript should be typed in 12-point Times New Roman type and double-spaced throughout, and should be arranged as follows: 1) Title, 2) Abstract, 3) Minimum 5 key words, 4) Introduction, 5) Materials and Methods, 6) Results, 7) Discussion, 8) Conclusion, 9) Authors Contributions, 10) Acknowledgments, 11) Disclosures of Conflict of Interest, 12) Sources of Funding, 13) Clinical trial Registry number (if applicable), 14) PROSPERO or other Registry number (if applicable), 15) Details of AI assisted tools, if used, 16) References, and 17) Figure legends
Editorials, Review, Resident’s Corner, Clinico-Pathological Conference
Should begin with 1) Introduction, 2) Main topic, 3) Conclusion, 4) Authors Contributions, 5) Acknowledgments, 6) Disclosures of Conflict of Interest, 7) Sources of Funding, 8) References, and 9) Figure legends
A list of three to ten keywords contained in the article must be listed below the abstract. A minimum of three and maximum ten keywords are required, and they should contain the type of research such as systematic review, randomized clinical trial, cohort study, case-control study, laboratory research, case report. Selecting the keywords is important because they will be used to search for the article on PubMed and other Internet resources. MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed. Authors are encouraged to use keywords from MeSH database (https://www.ncbi.nlm.nih.gov/mesh/).
The body of the manuscript must be organized into a format appropriate for the type of article using bold headings as listed in the following table:
| Primary Research | Literature Reviews | Case Reports |
|---|---|---|
| Introduction | Introduction | Introduction |
| Materials & Methods | Methods | Case Description |
| Results | Results | Discussion |
| Discussion | Discussion | Conclusion |
| Conclusion | Conclusion | Clinical Significance |
| Clinical Significance | Clinical Significance | References |
| References | References |
Describe the study's context or background (that is, the nature of the problem and its significance). Indicate the precise aim or goal of the research, as well as any hypotheses that were tested during the study or observation. Cite only references that are relevant; do not include information or findings from the work being described.
This section should carefully describe the study design, selection of the observational or experimental subjects (human or animals) and methods and materials used, including sample size and statistical approaches. Commonly used techniques or methods should be referred to appropriate references and should be described in brief. However, unique experiments, methods, technique should be described in adequate detail to allow other workers to reproduce the results. The Methods section should include a statement indicating that the research was approved by an independent local, regional or national review body (e.g., ethics committee, institutional review board). Information regarding mandatory clinical trial registration and patient consent (including the type of consent) should be provided. Refer “Protection of Research Participants” for more details. Experimental methodology should be concisely and appropriately explained. Commercially produced materials, devices, software must be followed by name of manufacturer and location. Statistical methods should be clearly specified. Provide adequate information about statistical techniques so that a knowledgeable reader with access to the source data can evaluate the methods' suitability for the study and confirm the stated results. Quantify results where possible and display them with the proper measurement error or uncertainty indications (such as confidence intervals). For further information, refer https://www.icmje.org/recommendations/browse/manuscript-preparation/preparing-for-submission.html
This section should succinctly state the results without any lengthy discussion or interpretation of individual data. Only the most significant observations should be highlighted or summarised; do not repeat all the information from the tables or figures in the text. Data should be provided for all primary and secondary outcomes listed in the Methods Section. Technical information and supplemental materials can be included in an appendix, where they will be available, but won't disrupt the text's flow. Statistical tests should be clearly defined, and statistical significance should be shown in both figures and tables with the help of superscripts such as a, b, c, rather than *, ¶, # or other nonsequential symbols.
The discussion should focus on the new and important findings of the study. The observations should be related to other relevant studies in a logical sequence. It should summarize, but not repeat the Results. The Discussion should end with a summary of the data and conclusions. Avoid making unqualified comments or drawing conclusions that are not sufficiently supported by the data. Instead, connect the results to the study's objectives. Make a distinction between clinical and statistical significance, and refrain from discussing economic costs and advantages unless the paper contains the necessary economic data and analyses. Avoid claiming priority or making references to incomplete work. When necessary, present new hypotheses; nevertheless, clearly identify them. Limitations of the study should also be mentioned.
To include the conclusions of the study and the future research directions.
This section should include 3 – 4 sentences about the clinical significance of the study results.
Include a list of abbreviations along with its description used in the manuscript. Use only standard abbreviations. The spelled-out abbreviation followed by the abbreviation in parentheses should be used on first mention unless the abbreviation is a standard unit of measurement.
Bibliography should list references in order of their appearance in the text (not alphabetically) and should follow PubMed Central guidelines along with Vancouver Style. References should follow the standards summarized in the NLM’s Sample References webpage (https://www.nlm.nih.gov/bsd/uniform_requirements.html) and detailed in the NLM’s Citing Medicine, 2nd edition (https://www.ncbi.nlm.nih.gov/books/NBK7256/ ). Place the number of the references at the end of the sentence as superscript to which the reference is related. Use commas to separate multiple reference numbers.
For example: "Bond strength of composite resin to dentin is influenced by the presence of a smear layer.4,5,8-15
If more than one reference is contained in a sentence, then number the reference immediately following the text that refers to the reference. For example: "Bailey2 found that 46% showed signs of metastasis while Varner3 found only 28%."
Sample examples of the references are mentioned below:
AL-Harbi SA, Farsi N. Microleakage of Ormocer-based restorative material in primary teeth: an in vivo study [abstract]. J Clin Pediatr Dent 2007;32(1):13-18.
Keith H Bridwell, Ronald L DeWald. The textbook of spinal surgery. 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins 2011. 2112 p.
Suken A Shah, Harvey Smith. Operative treatment of neuromuscular spinal deformity. In: Thomas JE, Baron SL, Andrew WM., editors. Surgical Management of Spinal Deformities. Philadelphia, PA: Saunders Elsevier, 2009;p 157-166.
Mayer M. Minimally Invasive Spine Surgery: A surgical manual. Berlin, Heidelberg: Springer 2005;2 496 p.
Ali A Baaj, Praveen V Mummaneni. Handbook of Spine Surgery. 2011, 480 p. Available at: http://books.google.co.in/books/about/Handbook_of_Spine_Surgery.html?id=-MRYK8l40SYCandredir_esc=y
Prasanthi LK. A study to determine the effectiveness of snake and ladder game on common ailments’ among primary school children of a selected school, Bengaluru 2008.
Lawrence, Ruth A. A review of the medical benefits and contraindications to breastfeeding in the United States [Internet]. Arlington (VA): National Center for Education in Maternal and Child Health; 1997 Oct [cited 2000 Apr 24]. p. 40. Available from: http://www.ncemch.org/pubs/PDFs/breastfeedingTIB.pdf
When preprints are cited in submitted manuscripts, the citation should clearly indicate that the reference is a preprint. You should include the word “preprint” following the citation information in the reference list and indicate that the cited material is a preprint in the text. The citation should include the link to the preprint and DOI if the preprint archive issues DOIs.
Figures
Each figure (photograph, image, artwork, flowchart, or any other illustration) should be submitted as a separate file and numbered in the same order as referenced in the manuscript. Each figure should be labelled and accompanied by a figure legend within the text document. Figures should be designed with the PDF layout in mind and should not exceed one page in length. For figures with multiple panels, clearly indicate each panel using labels (A), (B), (C), (D), etc. Ensure any required labels or arrows are added to images before uploading. Text within figures should be legible and of high quality, with the smallest visible text no less than eight points in height when viewed at actual size. Images should be a minimum of 600 by 450 pixels (proportional height) in size when in landscape orientation, with a resolution of at least 300 pixels per inch. Graphs should be approximately 500 pixels wide to ensure all labelling is readable and data points are clearly visible.
Scientific images (such as clinical images, radiographic images, micrographs, gels, etc.) prepared for publication must maintain the integrity of the original image data. Digital adjustments, including brightness, contrast, or colour modifications applied uniformly to the entire image, are acceptable provided they do not selectively highlight, misrepresent, obscure, or eliminate specific elements in the original figure, including the background. Cropping may be employed for efficient image display or to de-identify patients, but it must not misrepresent or alter the interpretation of the image by selectively eliminating relevant visual information.
The submission and publication of images generated by AI, machine learning, or similar technologies are discouraged unless explicitly part of the formal research design or methods. If submitted, clear descriptions of the content created, including the name of the model or tool, version and extension numbers, and manufacturer, must be provided. Authors bear responsibility for ensuring the integrity of the content generated by these models and tools.
Graphs and line drawings should have a minimum resolution of 1000 dpi. Graphs should include clearly labelled error bars, as described in the figure legend. Chemical structures should be prepared using ChemDraw or a similar program.
To prevent file transmission and electronic manuscript processing errors, it is advised to avoid substantially larger images. Radiographs, drawings, and graphs can be in black and white, but colour images are preferred. Images can only be submitted in TIFF, PSD, PNG, and JPEG file formats. If images are produced in PowerPoint, they must be saved as a JPEG file before uploading during the submission process.
Example,
Figure 4: Histologic features demonstrating perivascular eosinophilic condensation and hyalinization (H&E stain at 20x magnification).
Call outs must be placed in the body of the manuscript to indicate where an image is to be located. Example:
"The giant cells were seen multifocally rather than evenly dispersed throughout the background stroma. Of particular note, blood vessels within the stroma showed a prominent condensation and hyalinization of the peripheral collagen (Figure 4).
Tables
Tables should be submitted as separate Word files, with each table numbered using Arabic numerals. Tables should be cited in the text in consecutive numerical order. Additionally, each table should include a caption or title explaining its components. Footnotes to tables should be indicated by superscript lowercase letters (or asterisks for significance values and other statistical data) and included beneath the table body.
Example,
“A total of 44 patients who were admitted with depressed skull fracture and who underwent operative treatment were included in the study where in there were 30 males and 14 females. The mean age of patients was 26.95 ± 14.87 years (range being from 6years to 65 years). More than half of the patients were in the age group of 15-35 years (Table 1).
Table 1: Demographic and hospital stay
We have the capacity to link a video with your article on our website. The videos submitted should have an educational and not commercial purpose.
--Videos are considered to be part of the article and should not have been previously "published" (posted on another journal's website) or permission must be obtained for reuse.
--Files should be in .wmv, .avi, or .mp4 format. Typically, they should be no larger than 10 MB and no longer than 5 minutes.
--Videos should be uploaded at the time of submission with the manuscript files.
Less important data, which cannot be included in the main article due to size limitations or format restrictions (such as videos, raw data traces, and Power Point presentations), can be submitted as supplementary material along with the manuscript. This supplementary material will be displayed alongside the published article, assigned a DOI, and published as received from the author without any conversion, editing, or reformatting.
Since supplementary material is not typeset, it is crucial to ensure that all information is clearly presented without tracked changes, highlighted text, or line numbers. Additionally, each file should include an appropriate caption. To prevent discrepancies between the published article and the supplementary material, submit them as separate files without providing a title, author list, affiliations, or correspondence.
Supplementary material can be uploaded in various formats, including Word, Excel, CSV, CDX, FASTA, PDF, PowerPoint, JPEG, PNG, TIFF, MP3, MP4, WMA, WMV, or as Zip files.
Once all the preparation is complete and you have all the information and files ready for submission, please go to the Homepage and register as an author through ‘Our New Author Registration’. Once you are registered on the web site, you will be sent a username and password to the provided e-mail address. Using the same, you will login into the journal’s web site https://www.jpmer.com/journalDetails/JPMER and select Author.
After logging into the author’s account, follow the steps for submission available under Manual for Manuscript Submission. Once the submission is completed, you will get a system generated ID for eg. JPJ1296170815. Using this ID, you can track the status of your manuscript from submission till publication https://www.jpmer.com/manuscriptTrack/JPMER.
Submissions that pass the in-house and peer review process may be returned to authors for revision. This serves as an invitation to enhance the paper to its highest quality for further evaluation by the journal; it should not be construed as an acceptance. When submitting a revision, the following files need to be uploaded as separate documents:
• Revised manuscript
• Clarifications to reviewer’s comments
• Conflict of Interest Disclosure Form
• Authorship and Copyright Transfer Form
• Open Access License Agreement Form
In the revised manuscript, corrections should be clearly highlighted. The clarification letter should address the reviewer's comments point by point and provide detailed explanations for the errors. Only the elements of the manuscript requiring revision or correction should be included. All authors of the original paper must agree to the requested changes. The contribution to the field statement should clearly explain the reason for the correction.
Depending on the extent of the required corrections, peer review may be necessary. Authors should be aware that requests for changes beyond those outlined here may not be accepted for publication.
Once the article is accepted, a confirmation email will be sent to the corresponding author. Prior to publication, a galley proof of the article will be provided to the corresponding author for necessary changes.
Once the galley proof of the accepted article is prepared, it will be sent to the corresponding author. Along with editing text, authors can provide feedback on figures/tables and are required to respond to queries provided in the query form accompanying the PDF proof.
Utilizing web-based proofing streamlines the process, allowing authors to directly input corrections, minimizing potential errors. This proof should be used solely to verify typesetting, editing, and the accuracy of the text, tables, and figures. Any significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor.
It is crucial to ensure that all corrections are communicated in a single response. Authors are urged to carefully review the proofs within 48 to 72 hours of receipt, as specified in the cover letter accompanying the page proofs..
TThe final typeset and edited version of the journal article will be available on journal website under the ‘Online First’ tab. Once an Online First article is assigned to its final issue and given its bibliographic data, such as volume, issue, and first page number, the hosting of the article online transitions from the Online First listing to that of the completed issue.
Corrigendum/Addendum: Authors who identify errors that could impact the scholarly record or the integrity of their paper are encouraged to submit a correction online.
Erratum: If authors discover discrepancies between their approved galley proofs and the final published article that affect the scholarly record or the integrity of the paper, they are encouraged to submit an erratum request.
For more details, refer to the Policy page https://www.jpmer.com/journal/JPMER/page/policy.
Reprints of articles can be obtained on special request by paying a nominal amount. Please write an e-mail to Tushar Nanda at tushar.nanda@jaypeebrothers.com for the same.
If you need any assistance regarding the submission of your manuscript, you may please contact at editor@jaypeebrothers.com/ editor@jpmer.com.
The following documents should be uploaded in the manuscript system.
The following declaration forms should be uploaded in the manuscript system
Document Templates
EQUATOR Network reporting guidelines (https://www.equator-network.org/reporting-guidelines/) must be followed depending on the type of study. At the time of submission, the authors should upload the relevant checklist for the specific study type. The EQUATOR wizard (https://www.goodreports.org/) can help you find the right reporting checklist and appropriate guideline for your type of study. Other resources can be found at NLM’s Research Reporting Guidelines and initiatives (https://www.nlm.nih.gov/services/research_report_guide.html). The paper will be returned to the authors without review if the checklist is applicable to the paper but not completed.
| Checklists | Study | Designs Template |
|---|---|---|
| CARE | For Case Reports | Download |
| CONSORT | For Randomized Controlled Trials | Download |
| PRISMA | for Systematic Review and Meta-analyses | Download |
| STROBE | For Observational Studies | Download |
| SPIRIT | For Clinical Trials Protocol studies | Download |
| ARRIVE | For Animal studies | Download |
If you cannot find the template for your study design here, please visit https://www.equator-network.org/reporting-guidelines/.
© Jaypee Brothers Medical Publishers (P) LTD.
